PA
CPIX icon

Perceptive Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Perceptive Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$628K Sell
96,982
-99,996
-51% -$479K 0.01% 106
2026
Q1 		$640K Sell
196,978
-144,109
-42% -$555K 0.01% 90
2025
Q4 		$1.36M Buy
+341,087
New +$1.01M 0.02% 107

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Perceptive Advisors's CPIX Position: Q2 2026 in Review

Perceptive Advisors reduced its Cumberland Pharmaceuticals (CPIX) stake by 51% in Q2 2026, selling an estimated $479K and leaving 96,982 shares worth $628K. The position accounts for 0.01% of the portfolio, ranked #106.

Perceptive Advisors first reported a position in CPIX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.36M in Q4 2025. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Perceptive Advisors held 96,982 shares of Cumberland Pharmaceuticals worth $628K as of Q2 2026.
  • Perceptive Advisors sold 99,996 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $479K.
  • Cumberland Pharmaceuticals made up 0.01% of Perceptive Advisors's portfolio in Q2 2026, its #106 holding.
  • Perceptive Advisors first reported a position in Cumberland Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Perceptive Advisors's Cumberland Pharmaceuticals position peaked at $1.36M in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.